AI assistant
Sending…
OptimizeRx Corp — Director's Dealing 2014
Jul 24, 2014
33090_dirs_2014-07-24_c58f32e3-95a3-4d10-9248-edb690aba991.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2014-07-24
Reporting Person: Radoff Bradley Louis (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-07-24 | Common Stock, par value $0.001 per share | S | 631100 | $1.4095 | Disposed | 2289200 | Direct |
Footnotes
F1: $1.4095 is the weighted average sale price for the 631,100 shares sold on July 24, 2014. The shares were sold in 8 transactions at prices ranging from $1.40 to $1.50 per share, inclusive. The reporting person will provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
More from OptimizeRx Corp
Regulatory Filings
2026
May 12
Annual Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Director's Dealing
2026
Feb 13
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23